Comment Number: 522418-01920
Received: 6/12/2006 8:24:00 PM
Organization:
Commenter: Linda McCloud
State: IL
Subject: Business Opportunity Rule
Title: Notice of Proposed Rulemaking
CFR Citation: 16 CFR Part 437
No Attachments

Comments:

Dear Sir or Madam: I am very concerned about the proposed Business Opportunity Rule R511993. I believe that in its present form, it could prevent me from continuing as a distributer of glyconutrients. I understand that part of the FTC’s responsibilities is to protect the public from “unfair and deceptive acts or practices,” but some of the sections in the proposed rule will make it very difficult if not impossible for me to educate consumers and sell my products. The proposed seven day waiting period to enroll new customers a sales kit that only costs $99. People buy TVs, cars, and other items that cost much more than that and they do not have to wait seven-days. This waiting period gives the impression that there might be something wrong with the plan. I also think this seven-day waiting period is unnecessary, because [Mannatech already offers a 90% buyback policy (10% reshelving fee-- consistent with industry habits) for all products including sales kits purchased by a salesperson within the last twelve months. Under this proposed waiting period requirement, I will need to keep very detailed records when I first speak to someone about [glyconutrients and will then have to send in many reports to the headquarters. The proposed rule also calls for the release of any information regarding lawsuits involving misrepresentation, or unfair or deceptive practices. It does not matter if the company was found innocent. Today, anyone or any company can be sued for almost anything. It does not make sense to me that I would have to disclose these lawsuits unless Mannatech is found guilty. Otherwise, I am put at an unfair advantage even though the corporation has done nothing wrong. Finally, the proposed rule requires the disclosure of a minimum of 10 prior purchasers nearest to the prospective purchaser. I am glad to provide references, but in this day of identity theft, I am very uncomfortable giving out the personal information of individuals (without their approval) to strangers. Also, giving away this information could damage the business relationship of the references who may be involved in other companies or businesses including those of competitors. In order to get the list of the 10 prior purchasers, I will need to send the address of the prospective purchaser to Mannatech headquarters and then wait for the list. I also think the following sentence required by the proposed rule will prevent many people from wanting to sign up as a salesperson “If you buy a business opportunity from the seller, your contact information can be disclosed in the future to other buyers.” People are very concerned about their privacy and identity theft. They will be reluctant to share their personal information with individuals they may have never met. [I have been a nurse practitioner for seven years and a Mannatech distributor for about eighteen months. Glyconutrients are going to revolutionize the way the medical community helps patients because of the well-documented science that is available, NOT the testimonials. I cannot obtain these nutrients through any other medium and would have never learned of them without someone taking an interest in educating me. I am very concerned that the FTC is more concerned about protecting the pharmaceutical industry, the big monopolies on which we are so dependent. I appreciate the work of the FTC to protect consumers, but I believe this proposed new rule has many unintended consequences and that there are less burdensome alternatives available in achieving its goals. Thank you for your time in considering my comments. Sincerely, Linda McCloud